Chondromyxoid Fibroma of the Sternum in a 63-Year-Old Woman by Kilic, Dalokay et al.
© 2015 by the Texas Heart ® 
Institute, Houston
Volume 42, Number 4, 2015400      http://dx.doi.org/10.14503/THIJ-14-4381
Chondromyxoid Fibroma 
of the Sternum in a 
63-Year-Old Woman
Primary chondromyxoid fibroma is a benign bone tumor. Its localization in the sternum is 
quite rare; we found only 6 relevant reports. We report our diagnosis and treatment of a 
chondromyxoid fibroma in the sternum of a 63-year-old woman. The patient underwent 
subtotal sternectomy and chest-wall reconstruction with use of a titanium rib bridge system 
and Prolene mesh. The patient’s clinical course was uneventful, and she had no local recur-
rence 41 months postoperatively. Our review herein of the 6 previous cases reveals that our 
patient is the oldest thus far to have been diagnosed with a sternal chondromyxoid fibroma. 
(Tex Heart Inst J 2015;42(4):400-2)
C hondromyxoid fibroma (CMF) is a benign bone tumor that constitutes 0.5% to 1% of primary bone neoplasms.1 It typically occurs in the metaphyses of long bones such as the tibia; its localization in the sternum is extremely rare. 
We present a case of primary CMF of the sternum, and we review the few previously 
reported cases.
Case Report
In November 2010, a 63-year-old-woman was admitted to our hospital with chest 
pain and a 10-year history of swelling of the sternum. She had an irregular, palpable 
mass (diameter, 10 cm) in the upper two thirds of the sternum (Fig. 1). A radio-
graph revealed a bone tumor in the sternum. A computed tomogram (CT) showed 
an osteolytic lesion with discrete calcif ic deposits in the sternal bone marrow (Fig. 
2). Positron emission tomography (PET) of the mass with 18F-f luorodeoxyglucose 
(18F-FDG) contrast medium revealed a maximal standardized uptake value (SUV 
max) of 5.7. Upon histologic analysis, a biopsy specimen obtained with use of an 
ultrasonographically guided Tru-Cut® needle (CareFusion Corporation; Waukegan, 
Ill) yielded a benign tumor. The tumor had a slightly lobular architecture and was 
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Fig. 1  Intraoperative photograph 
shows a mass on the sternum.
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composed of a myxoid matrix populated by stellate and 
spindle cells, with moderate nuclear enlargement and 
eosinophilic cytoplasmic processes (Fig. 3). The diag-
nosis was CMF.
 We performed a subtotal sternectomy and resected 
the mass with a clear surgical margin. Rigid sternal re-
construction was achieved with use of the Stratos 
Strasbourg Thoracic Osteosyntheses System (MedX-
pert GmbH; Eschbach, Germany). After the ribs were 
prepared laterally to the margin of resection, the rib 
clips and connecting bar of the Stratos were bent to 
proper shape and fitted to reconstruct the chest defect. 
The patient’s clinical course was uneventful, and she 
had no local recurrence as of March 2014.
Fig. 2  Computed tomogram shows an osteolytic lesion with 
discrete calcification in the bone marrow of the upper sternum.
Fig. 3  Photomicrograph shows moderate nuclear enlargement 
and prominent eosinophilic cytoplasmic processes (H & E, orig. 
×200).
TABLE I. Reports of Chondromyxoid Fibroma of the Sternum
 Diagnosis
   Symptoms Preoperative Preoperative Tumor Follow-Up 
    Reference Age (yr) Sex (duration) Histologic Radiologic Size (cm) (mo)**
Teitelbaum SL 17 F Precordial ABC and ABC 12 × 5.5 24 
and Bessone L2   pain and mass CMF    
(1969)   (3 mo)    
Alonso-Lej F 53 M Dyspnea and Benign lesion Benign lesion 20 × 16 × 6* 18 
and De Linera   mass     
FA3 (1971)   (1 yr)    
Wuisman P, 43 M Chest pain  CMF Chondrosarcoma Unspecified 12 
et al.4   (6 mo)     
(1993)       
Lyzak JS, 35 F Chest pain None Chondrosarcoma 3.7 × 1.7 1.5 
et al.5   (3 yr)     
(1996)       
Song DE, 47 M Chest pain CMF Chondrosarcoma 8 × 5.5 × 3 10 
et al.6   (7 yr)     
(2003)       
Takao E, 17 M Chest pain CMF Malignant Unspecified 42 
et al.7   (2 yr)  cartilaginous   
(2006)     tumor  
Current 63 F Chest pain Benign lesion Chondrosarcoma 10 × 9 × 5 41 
case   and mass     
   (10 yr)    
 
ABC = aneurysmal bone cyst; CMF = chondromyxoid fibroma; F = female; M = male 
 
  *Tumor (size, 24 × 18 × 14 cm) had spread to the mediastinum. 
**No patient had evidence of neoplasm recurrence.
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Discussion
To our knowledge, this is the 7th case of primary sternal 
CMF to be reported in the English-language medical 
literature (Table I).2-7 The patients’ ages have ranged 
from 17 to our patient’s 63 years.
 Clinically, the predominant symptom is chest pain, 
as in our patient. Radiologically, CMF most often pre-
sents as a sharply demarcated, lytic lesion with scalloped 
margins.8 Some authors whose patients had a primary 
sternal CMF suspected a chondrosarcoma or malignant 
cartilaginous tumor preoperatively (Table I) because of 
cortical destruction and expansion shown on CT.4-7 Our 
patient’s CT showed an osteolytic lesion with discrete 
calcification in the bone marrow of the upper sternum. 
Low-grade chondrosarcoma, like CMF, can have a pre-
dilection for low 18F-FDG uptake, so the differential 
diagnosis of primary bone malignancies can be con-
founding. Factors that might contribute to the lower 
avidity include a high proportion of acellular gelatinous 
matrix with respect to cellular density, and lower mi-
totic rates than those in higher-grade tumors.9 In our 
patient’s mass, FDG uptake evaluated by means of PET 
had an SUV max of 5.7. Because of the radiologic find-
ings, we performed a biopsy in order to narrow the dif-
ferential diagnosis.
 Primary sternal tumors include chondroma, chondro-
sarcoma, and osteochondroma. Particular caution is 
required to differentiate chondrosarcoma from CMF. 
Because of the presence of pleomorphic cells with hy-
perchromatic nuclei, the histologic diagnosis of CMF 
might be diff icult and result in an erroneous diagno-
sis of chondrosarcoma.2 The preoperative histologic 
specimens were evaluated correctly in some previous 
cases.2,4,6,7 In our patient, the preoperative histologic di-
agnosis was a benign lesion.
 En bloc resection with clear margins is satisfactory 
treatment for CMF. As in our patient, no recurrence 
has been reported (Table I).
 Chest-wall reconstruction with use of rigid material 
is necessary in cases of wall resections larger than 5 
cm. In our patient, we used the Stratos, which has 
rigid material composed of moldable titanium bars and 
rib clips. Gonfiotti and colleagues10 used a Stratos 
for sternal reconstruction after subtotal sternectomy 
for primary tumors in one patient. We have used this 
graft in 5 subsequent sternectomy patients and prefer it 
when large resections of the chest wall include the entire 
sternum, cartilage, and medial ends of the clavicle. All 
our patients thus treated were extubated in the early 
postoperative period, and paradoxical respiration was 
not observed during a mean follow-up period of 28 ± 9 
months (range, 18–41 mo). In addition, we have used 
Prolene mesh, to avoid lung herniation.
 In our experience, the Stratos adapts progressively 
and well to each required sternal shape, because of 
the flexibility of the titanium bars and the absence of 
dead parietal spaces. We think that the Stratos plus 
Prolene mesh should be considered in the reconstruc-
tion of large chest-wall defects (including the sternum), 
because it results in minimal morbidity, is easy to use, 
prevents paradoxical respiration, and provides a good 
cosmetic appearance, as in our patient with CMF.
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